355 related articles for article (PubMed ID: 35198437)
1. Treatment Response Prediction Using Ultrasound-Based Pre-, Post-Early, and Delta Radiomics in Neoadjuvant Chemotherapy in Breast Cancer.
Yang M; Liu H; Dai Q; Yao L; Zhang S; Wang Z; Li J; Duan Q
Front Oncol; 2022; 12():748008. PubMed ID: 35198437
[TBL] [Abstract][Full Text] [Related]
2. An ultrasound-based nomogram model in the assessment of pathological complete response of neoadjuvant chemotherapy in breast cancer.
Liu J; Leng X; Liu W; Ma Y; Qiu L; Zumureti T; Zhang H; Mila Y
Front Oncol; 2024; 14():1285511. PubMed ID: 38500656
[TBL] [Abstract][Full Text] [Related]
3. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a personalized nomogram of ultrasound for pretreatment prediction of breast cancer patients sensitive to neoadjuvant chemotherapy.
Zhang MQ; Du Y; Zha HL; Liu XP; Cai MJ; Chen ZH; Chen R; Wang J; Wang SJ; Zhang JL; Li CY
Br J Radiol; 2022 Dec; 95(1140):20220626. PubMed ID: 36378247
[TBL] [Abstract][Full Text] [Related]
6. Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Guo L; Du S; Gao S; Zhao R; Huang G; Jin F; Teng Y; Zhang L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884576
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study.
Du Y; Cai M; Zha H; Chen B; Gu J; Zhang M; Liu W; Liu X; Liu X; Zong M; Li C
Eur Radiol; 2024 Jan; 34(1):136-148. PubMed ID: 37518678
[TBL] [Abstract][Full Text] [Related]
8. Development of an ultrasound-based radiomics nomogram to preoperatively predict Ki-67 expression level in patients with breast cancer.
Liu J; Wang X; Hu M; Zheng Y; Zhu L; Wang W; Hu J; Zhou Z; Dai Y; Dong F
Front Oncol; 2022; 12():963925. PubMed ID: 36046035
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients.
Chen S; Shu Z; Li Y; Chen B; Tang L; Mo W; Shao G; Shao F
Front Oncol; 2020; 10():1410. PubMed ID: 32923392
[No Abstract] [Full Text] [Related]
10. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Based on Dynamic Contrast-Enhanced MRI to Early Predict Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Therapy.
Zeng Q; Ke M; Zhong L; Zhou Y; Zhu X; He C; Liu L
Acad Radiol; 2023 Aug; 30(8):1638-1647. PubMed ID: 36564256
[TBL] [Abstract][Full Text] [Related]
12. A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma.
Sun MX; Zhao MJ; Zhao LH; Jiang HR; Duan YX; Li G
Radiat Oncol; 2023 Apr; 18(1):67. PubMed ID: 37041545
[TBL] [Abstract][Full Text] [Related]
13. A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.
Lin P; Yang PF; Chen S; Shao YY; Xu L; Wu Y; Teng W; Zhou XZ; Li BH; Luo C; Xu LM; Huang M; Niu TY; Ye ZM
Cancer Imaging; 2020 Jan; 20(1):7. PubMed ID: 31937372
[TBL] [Abstract][Full Text] [Related]
14. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers.
Wang Z; Lin F; Ma H; Shi Y; Dong J; Yang P; Zhang K; Guo N; Zhang R; Cui J; Duan S; Mao N; Xie H
Front Oncol; 2021; 11():605230. PubMed ID: 33692950
[TBL] [Abstract][Full Text] [Related]
15. Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.
Zhang K; Lin J; Lin F; Wang Z; Zhang H; Zhang S; Mao N; Qiao G
J Xray Sci Technol; 2023; 31(4):669-683. PubMed ID: 37066960
[TBL] [Abstract][Full Text] [Related]
16. Computed Tomography-Based Radiomics Analysis for Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Duan Y; Yang G; Miao W; Song B; Wang Y; Yan L; Wu F; Zhang R; Mao Y; Wang Z
J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):199-204. PubMed ID: 36790871
[TBL] [Abstract][Full Text] [Related]
17. Integration of ultrasound radiomics features and clinical factors: A nomogram model for identifying the Ki-67 status in patients with breast carcinoma.
Wu J; Fang Q; Yao J; Ge L; Hu L; Wang Z; Jin G
Front Oncol; 2022; 12():979358. PubMed ID: 36276108
[TBL] [Abstract][Full Text] [Related]
18. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Ki-67 of Invasive Ductal Breast Cancer Based on Ultrasound Radiomics Nomogram.
Zhu Y; Dou Y; Qin L; Wang H; Wen Z
J Ultrasound Med; 2023 Feb; 42(3):649-664. PubMed ID: 35851691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
